By Sasha TerMaat
Co-Chair, EHRA Executive Committee
The final 2019 IPPS rule included changes to the Promoting Interoperability/ Meaningful Use program beginning January 1, 2019. Disappointingly, with only six weeks between the close of the public comment period for the proposed rule in late June and the publication of the final rule in early August, CMS’ rushed process and failure to fully consider stakeholder comments (including EHRA’s) led to a rule filled with measures that will be unworkable, inefficient, and onerous.
In a previous blog we delved into PDMP query as just one of the measures where EHR developers anticipate challenges. In that case it’s due to differing levels of PDMP integration with CEHRT and inconsistent references within the rule about whether the query needs to be made via CEHRT, along with other areas in which the measure is ambiguous.
In this blog post, let’s look at the reasons we’re concerned about a different measure, this one related to opioid treatment agreements.
On August 2, 2018, CMS published the 2600-page pre-publication version of the
Cyber-threats are all over the news, including attempts to hack elections, steal corporate trade secrets, and hold medical records for ransom. Phishing is rampant, and is the way most hackers ultimately get into secure systems. The U.S. government has, of course, taken notice, and is taking action on several fronts.
EHRA member companies were out in force at